131 related articles for article (PubMed ID: 18305230)
1. Role of glutamate residues in substrate recognition by human MATE1 polyspecific H+/organic cation exporter.
Matsumoto T; Kanamoto T; Otsuka M; Omote H; Moriyama Y
Am J Physiol Cell Physiol; 2008 Apr; 294(4):C1074-8. PubMed ID: 18305230
[TBL] [Abstract][Full Text] [Related]
2. Purification and reconstitution of polyspecific H
Kawasaki T; Matsumoto T; Iwai Y; Kawakami M; Juge N; Omote H; Nabekura T; Moriyama Y
Biochim Biophys Acta Biomembr; 2018 Nov; 1860(11):2456-2464. PubMed ID: 30028956
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of testis-specific rodent multidrug and toxic compound extrusion 2, a class III MATE-type polyspecific H+/organic cation exporter.
Hiasa M; Matsumoto T; Komatsu T; Omote H; Moriyama Y
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1437-44. PubMed ID: 17715386
[TBL] [Abstract][Full Text] [Related]
4. Functional characteristics of two human MATE transporters: kinetics of cimetidine transport and profiles of inhibition by various compounds.
Ohta KY; Inoue K; Yasujima T; Ishimaru M; Yuasa H
J Pharm Pharm Sci; 2009; 12(3):388-96. PubMed ID: 20067714
[TBL] [Abstract][Full Text] [Related]
5. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney.
Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y
J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731
[TBL] [Abstract][Full Text] [Related]
6. Wide variety of locations for rodent MATE1, a transporter protein that mediates the final excretion step for toxic organic cations.
Hiasa M; Matsumoto T; Komatsu T; Moriyama Y
Am J Physiol Cell Physiol; 2006 Oct; 291(4):C678-86. PubMed ID: 16641166
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Human Multidrug and Toxic Compound Extrusion (MATE) Transporters in Testosterone Transport.
Goda M; Ikehara M; Sakitani M; Oda K; Ishizawa K; Otsuka M
Biol Pharm Bull; 2021; 44(4):501-506. PubMed ID: 33790101
[TBL] [Abstract][Full Text] [Related]
8. A conserved glutamate residue in transmembrane helix 10 influences substrate specificity of rabbit OCT2 (SLC22A2).
Zhang X; Shirahatti NV; Mahadevan D; Wright SH
J Biol Chem; 2005 Oct; 280(41):34813-22. PubMed ID: 16087669
[TBL] [Abstract][Full Text] [Related]
9. A human transporter protein that mediates the final excretion step for toxic organic cations.
Otsuka M; Matsumoto T; Morimoto R; Arioka S; Omote H; Moriyama Y
Proc Natl Acad Sci U S A; 2005 Dec; 102(50):17923-8. PubMed ID: 16330770
[TBL] [Abstract][Full Text] [Related]
10. Charge-to-substrate ratio during organic cation uptake by rat OCT2 is voltage dependent and altered by exchange of glutamate 448 with glutamine.
Schmitt BM; Gorbunov D; Schlachtbauer P; Egenberger B; Gorboulev V; Wischmeyer E; Müller T; Koepsell H
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F709-22. PubMed ID: 19211691
[TBL] [Abstract][Full Text] [Related]
11. A novel variant of mouse MATE-1 H+/organic cation antiporter with a long hydrophobic tail.
Kobara A; Hiasa M; Matsumoto T; Otsuka M; Omote H; Moriyama Y
Arch Biochem Biophys; 2008 Jan; 469(2):195-9. PubMed ID: 17983590
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine 112 is essential for organic cation transport by the plasma membrane monoamine transporter.
Ho HT; Wang J
Biochemistry; 2010 Sep; 49(36):7839-46. PubMed ID: 20687515
[TBL] [Abstract][Full Text] [Related]
13. Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate.
Gorboulev V; Volk C; Arndt P; Akhoundova A; Koepsell H
Mol Pharmacol; 1999 Dec; 56(6):1254-61. PubMed ID: 10570053
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 family.
Zhou M; Xia L; Engel K; Wang J
J Biol Chem; 2007 Feb; 282(5):3188-95. PubMed ID: 17121826
[TBL] [Abstract][Full Text] [Related]
15. Identification of essential histidine and cysteine residues of the H+/organic cation antiporter multidrug and toxin extrusion (MATE).
Asaka J; Terada T; Tsuda M; Katsura T; Inui K
Mol Pharmacol; 2007 Jun; 71(6):1487-93. PubMed ID: 17327464
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the human MATE2 proton-coupled polyspecific organic cation exporter.
Komatsu T; Hiasa M; Miyaji T; Kanamoto T; Matsumoto T; Otsuka M; Moriyama Y; Omote H
Int J Biochem Cell Biol; 2011 Jun; 43(6):913-8. PubMed ID: 21419862
[TBL] [Abstract][Full Text] [Related]
17. Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells.
Tsuda M; Terada T; Ueba M; Sato T; Masuda S; Katsura T; Inui K
J Pharmacol Exp Ther; 2009 Apr; 329(1):185-91. PubMed ID: 19164462
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification and functional characterization of rat multidrug and toxin extrusion type transporter 1 as an organic cation/H+ antiporter in the kidney.
Ohta KY; Inoue K; Hayashi Y; Yuasa H
Drug Metab Dispos; 2006 Nov; 34(11):1868-74. PubMed ID: 16928787
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1.
Terada T; Masuda S; Asaka J; Tsuda M; Katsura T; Inui K
Pharm Res; 2006 Aug; 23(8):1696-701. PubMed ID: 16850272
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 4',6-diamidino-2-phenylindole as a fluorescent probe substrate for rapid assays of the functionality of human multidrug and toxin extrusion proteins.
Yasujima T; Ohta KY; Inoue K; Ishimaru M; Yuasa H
Drug Metab Dispos; 2010 Apr; 38(4):715-21. PubMed ID: 20047987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
